✦ LIBER ✦

Targeting cancer: a NOvel way

✍ Scribed by Martina Habeck

Book ID: 114384433
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 29 KB
Volume: 8
Category: Article
ISSN: 1359-6446
DOI: 10.1016/s1359-6446(03)02769-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paving the way for targeting RSK in canc

Paving the way for targeting RSK in cancer

✍ Romeo, Yves; Roux, Philippe P 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 222 KB

Targeting non-multiplying organisms as a

Targeting non-multiplying organisms as a way to develop novel antimicrobials

✍ Anthony R.M. Coates; Yanmin Hu 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 432 KB

A novel strategy for cancer treatment: T

A novel strategy for cancer treatment: Targeting cancer stem cells

✍ Liu, Jia ;Ma, LeiNa ;Wang, YiGang ;Liu, XinYuan ;Qian, QiJun 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 495 KB

Targeting HIV reverse transcriptase in n

Targeting HIV reverse transcriptase in novel ways

✍ Gu, Zhengxian; Wainberg, Mark A. 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 677 KB

Fyn : A novel molecular target in cancer

✍ Yoshihito D. Saito; Ana R. Jensen; Ravi Salgia; Edwin M. Posadas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

## Abstract Fyn is 59‐kDa member of the Src family of kinases that is historically associated with T‐cell and neuronal signaling in development and normal cellular physiology. Whereas Src has been heavily studied in cancer, less attention has been traditionally awarded to the other Src kinases such

Peroxiredoxins, a novel target in cancer

Peroxiredoxins, a novel target in cancer radiotherapy

✍ Bo Zhang; Yan Wang; Yongping Su 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 205 KB